CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+9.18%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$672M
AUM Growth
+$672M
(+0.01%)
Cap. Flow
-$43M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
64.99%
Holding
33
New
6
Increased
11
Reduced
7
Closed
9
Top Buys
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$50.6M |
| 2 |
AbbVie
ABBV
|
$34.5M |
| 3 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
$25.3M |
| 4 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$23.4M |
| 5 |
HMSY
HMS Holdings Corp.
HMSY
|
$22.4M |
Top Sells
| 1 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$64M |
| 2 |
Myriad Genetics
MYGN
|
$48.1M |
| 3 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$35M |
| 4 |
Masimo
MASI
|
$29.7M |
| 5 |
United Therapeutics
UTHR
|
$21.5M |
Sector Composition
| 1 | Healthcare | 75.31% |
| 2 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Enanta Pharmaceuticals
ENTA
$180M
| $66.6M | 9.91% | 1,546,097 +291,638 | +23% | +$12.6M |
|
2
Orthofix Medical
OFIX
$592M
| $53.3M | 7.93% | 1,471,153 +372,483 | +34% | +$13.5M |
|
|
TARO
3
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $53.1M | 7.89% | 378,372 +103,140 | +37% | +$14.5M |
|
|
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
| $50.6M | 7.53% | +1,625,120 | New | +$50.6M |
|
|
5
United Therapeutics
UTHR
$13.8B
| $37.8M | 5.62% | 426,790 -242,900 | -36% | -$21.5M |
|
|
WX
6
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $37.6M | 5.59% | 1,143,315 +712,426 | +165% | +$23.4M |
|
|
INSY
7
DELISTED
Insys Therapeutics, Inc.
INSY
| $37.1M | 5.52% | 1,188,316 +385,929 | +48% | +$12.1M |
|
|
8
AbbVie
ABBV
$372B
| $34.5M | 5.13% | +611,300 | New | +$34.5M |
|
|
HPTX
9
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $33.4M | 4.97% | 1,279,048 +252,956 | +25% | +$6.6M |
|
10
Option Care Health
OPCH
$4.65B
| $33M | 4.9% | 3,950,839 -1,071,933 | -21% | -$8.94M |
|
|
OSIR
11
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $30.8M | 4.58% | 1,970,061 -84,963 | -4% | -$1.33M |
|
|
PTX
12
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $27.2M | 4.04% | 3,024,851 +1,807,648 | +149% | +$16.2M |
|
|
IPCM
13
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $25.3M | 3.77% | +573,209 | New | +$25.3M |
|
|
HMSY
14
DELISTED
HMS Holdings Corp.
HMSY
| $22.4M | 3.33% | +1,098,126 | New | +$22.4M |
|
|
15
Myriad Genetics
MYGN
$593M
| $19.8M | 2.94% | 507,682 -1,236,468 | -71% | -$48.1M |
|
|
AKRX
16
DELISTED
Akorn, Inc.
AKRX
| $17M | 2.53% | 512,085 +217,085 | +74% | +$7.22M |
|
|
DSCI
17
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $16.8M | 2.5% | 1,451,692 +560,137 | +63% | +$6.48M |
|
18
Supernus Pharmaceuticals
SUPN
$2.53B
| $15.8M | 2.35% | +1,440,008 | New | +$15.8M |
|
|
ANAC
19
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $15.7M | 2.34% | 888,206 -722,261 | -45% | -$12.8M |
|
|
TVTY
20
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $14.9M | 2.22% | 850,002 +255,904 | +43% | +$4.49M |
|
21
ANI Pharmaceuticals
ANIP
$2.03B
| $12.2M | 1.82% | 355,276 +104,013 | +41% | +$3.58M |
|
|
AVDL
22
Avadel Pharmaceuticals
AVDL
$1.43B
| $9.45M | 1.41% | 630,178 -417,398 | -40% | -$6.26M |
|
23
ADMA Biologics
ADMA
$4.12B
| $6.5M | 0.97% | +667,099 | New | +$6.5M |
|
|
FURX
24
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $1.43M | 0.21% | 13,440 -603,055 | -98% | -$64M |
|
25
Intuitive Surgical
ISRG
$170B
| – | – | -36,600 | Closed | -$16M |
|